PAHC | tickerfilter.com

Fundamental analysis

49%

Profitability 65%

Dept financing 20%

Liquidity 67%

Performance 35%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.30%

1 Month

8.95%

3 Months

38.92%

6 Months

40.50%

1 Year

245.25%

2 Year

329.10%

Key data

Stock price

$57.07

P/E Ratio

16.44

DAY RANGE

$54.50 - $57.48

EPS

$2.27

52 WEEK RANGE

$16.16 - $60.08

52 WEEK CHANGE

$245.25

MARKET CAP

1.514 B

YIELD

1.28%

SHARES OUTSTANDING

40.535 M

DIVIDEND

$0.12

EX-DIVIDEND DATE

03-04-2026

NEXT EARNINGS DATE

05-07-2025

BETA

1.14

PUBLIC FLOAT

AVERAGE 10 VOLUME

$269,552

AVERAGE 30 VOLUME

$316,512

Company detail

CEO: Jack C. Bendheim
Region: US
Website: pahc.com
Employees: 1,860
IPO year: 2014

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases.

PAHC - PHIBRO ANIMAL HEALTH CORP